Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 7.32 USD 3.39%
Market Cap: 536.8m USD
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Mind Medicine (MindMed) Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mind Medicine (MindMed) Inc
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Other Current Assets
$4.1m
CAGR 3-Years
80%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Other Current Assets
$883m
CAGR 3-Years
-22%
CAGR 5-Years
7%
CAGR 10-Years
1%
Canopy Growth Corp
TSX:WEED
Other Current Assets
CA$28.5m
CAGR 3-Years
-34%
CAGR 5-Years
-29%
CAGR 10-Years
30%
Sundial Growers Inc
NASDAQ:SNDL
Other Current Assets
CA$48.7m
CAGR 3-Years
56%
CAGR 5-Years
77%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Other Current Assets
$16.3m
CAGR 3-Years
17%
CAGR 5-Years
9%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Other Current Assets
$102.1m
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Mind Medicine (MindMed) Inc
Glance View

Market Cap
536.8m USD
Industry
Pharmaceuticals

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.

MNMD Intrinsic Value
2.22 USD
Overvaluation 70%
Intrinsic Value
Price

See Also

What is Mind Medicine (MindMed) Inc's Other Current Assets?
Other Current Assets
4.1m USD

Based on the financial report for Sep 30, 2024, Mind Medicine (MindMed) Inc's Other Current Assets amounts to 4.1m USD.

What is Mind Medicine (MindMed) Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
7%

Over the last year, the Other Current Assets growth was 70%. The average annual Other Current Assets growth rates for Mind Medicine (MindMed) Inc have been 80% over the past three years , 7% over the past five years .

Back to Top